James E Wagner Stock Debt To Equity
| JWCAF Stock | USD 0.0001 0.00 0.00% |
Fundamental analysis of James E allows traders to better anticipate movements in James E's stock price by examining its financial health and performance throughout various phases of its business cycle.
James |
James E Wagner Company Debt To Equity Analysis
James E's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current James E Debt To Equity | 1.39 % |
Most of James E's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, James E Wagner is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, James E Wagner has a Debt To Equity of 1.39%. This is 97.4% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The debt to equity for all United States stocks is 97.15% higher than that of the company.
James Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses James E's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of James E could also be used in its relative valuation, which is a method of valuing James E by comparing valuation metrics of similar companies.James E is currently under evaluation in debt to equity category among its peers.
James Fundamentals
| Return On Equity | -0.5 | |||
| Return On Asset | -0.13 | |||
| Operating Margin | (2.87) % | |||
| Current Valuation | 16.02 M | |||
| Shares Outstanding | 109.42 M | |||
| Shares Owned By Insiders | 1.16 % | |||
| Price To Book | 0.0002 X | |||
| Price To Sales | 0.33 X | |||
| Revenue | 2.82 M | |||
| Gross Profit | 1.12 M | |||
| EBITDA | (7.28 M) | |||
| Net Income | (9.25 M) | |||
| Cash And Equivalents | 321.04 K | |||
| Total Debt | 3.07 M | |||
| Debt To Equity | 1.39 % | |||
| Current Ratio | 1.92 X | |||
| Book Value Per Share | 0.15 X | |||
| Cash Flow From Operations | (9.47 M) | |||
| Earnings Per Share | (0.06) X | |||
| Beta | 0.0509 | |||
| Market Capitalization | 832.17 K | |||
| Total Asset | 28.97 M | |||
| Net Asset | 28.97 M |
About James E Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze James E Wagner's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of James E using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of James E Wagner based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| VOO | Vanguard SP 500 | |
| XLK | Technology Select Sector | |
| XLV | Health Care Select | |
| QQQ | Invesco QQQ Trust | |
| XLC | Communication Services Select |
Other Information on Investing in James Pink Sheet
James E financial ratios help investors to determine whether James Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in James with respect to the benefits of owning James E security.